BioHealth News Archive
Built For Bio: Jeff Galvin, CEO & Founder of American Gene Technologies
MCEDC discovers how Jeff is using the availability of raw talent and novel technology unique to Montgomery County, MD to help cure HIV and…
Read More
Top 50 NIH-Funded Institutions of 2019
The great American political divide shows no sign of ending as the United States lurches toward the 2020 presidential election. However, one of the…
Read More
Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness
Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract award by the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the…
Read More
REGENXBIO Announces First FDA Approval of a Gene Therapy Based on Its Proprietary NAV® Technology Platform | REGENXBIO Inc.
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary…
Read More
Gene therapy may have its first blockbuster – MIT Technology Review
A newborn. A fatal diagnosis. And soon, a one-time gene replacement cure in the first weeks of life. The cost? You don’t want to…
Read More
BIO Releases 5th Annual Emerging Therapeutic Company Trend Report Showing Record Year for Venture Capital Funding
Today, the Biotechnology Innovation Organization (BIO) released the 2019 Emerging Therapeutic Company Trend Report, highlighting ten years (2009-2018) of biotechnology funding and deal making across…
Read More
How to navigate the world of startups | Hub
For aspiring entrepreneurs, the thought of building a company from scratch can be daunting. What if no one wants to buy what you're selling?…
Read More
BIO Preview: Some of the Highlights of One of the World’s Premier Life Science Conventions | BioSpace
The BIO International Convention is being held in Philadelphia from June 3-6, with more than 16,000 attendees expected from around the world. The convention…
Read More
Tick tock: Register now, 2019 Technology Showcase
June 12, 2019! Register now for the 3rd annual Technology Showcase! The 2019 Technology Showcase will again highlight technologies being developed at the NCI and…
Read More
Johns Hopkins founded and BHCR Crab Trap Winner medical research firm LifeSprout gets financing boost – Baltimore Sun
A Baltimore-based regenerative medicine firm called LifeSprout, which makes synthetic products used to restore soft tissue, has secured $6.5 million in financing. {iframe}https://www.baltimoresun.com/business/bs-bz-lifesprout-financing-20190529-story.html{/iframe}
Read More
Baltimore firm raises $110 million to bring Johns Hopkins’ cancer-detecting blood test to market – Baltimore Sun
A newly formed Baltimore company has raised $110 million to commercialize a cancer-detecting blood test, developed by Johns Hopkins researchers, that doctors would give…
Read More
QIAGEN launches first FDA-approved companion diagnostic for PIK3CA biomarkers to enhance precision medicine in breast cancer
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the immediate launch of its therascreen® PIK3CA RGQ PCR Kit (therascreen PIK3CA Kit) after it…
Read More
With FDA Approval Of Zolgensma, Regenxbio Sets Out For First Revenue Stream – REGENXBIO Inc. (NASDAQ:RGNX) | Seeking Alpha
Regenxbio (RGNX) announced that a gene therapy developed based on its technology was approved by the FDA. This gene therapy product is known as…
Read More
NHLBI Funding & Research Opportunities and Announcements for May 3, 2019
Funding and Research Opportunities The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:…
Read More
Gaithersburg’s Viela Bio strikes $220M partnership with Hansoh Pharmaceutical Group – Washington Business Journal
It's the local company's first step toward establishing an international presence after it was spun out last year from MedImmune. {iframe}https://www.bizjournals.com/washington/news/2019/05/28/gaithersburg-s-viela-bio-strikes-220m-deal-with.html{/iframe}
Read More